Make an Appointment:

Call Cancer Connect at (860) 545-6000

Please have the following information available when you call:
  • Results of biopsies, x-rays, or other diagnostic studies you have had
  • Information about any prior treatments you have had
  • Your primary medical insurance information

Lung cancer is one of the few diseases on the rise in our country.

It’s taking the lives of more women each year than breast and colon cancer combined. The Helen & Harry Gray Cancer Center is leading the Connecticut and Western Massachusetts region in advancing research, screening and treatment for lung cancer. With five-year survival rates now topping 75% for Stage 1 lung cancer patients, breakthrough treatments are continually raising hope and improving outcomes.

A Multidisciplinary Team of Specialists Provide Individualized Care

We are a major referral center for patients with lung cancer, esophageal cancer and other chest tumors. Our team of specialists gathers weekly to determine on the most effective cancer treatments for individual thoracic cancer patients. With the wide perspective of experts from Thoracic Surgery, Medical Oncology, Radiation Oncology, Pulmonary Medicine, Pathology, Radiology and any other department required, patients get the most advanced cancer treatment possible.

Thoracic/Lung Cancer Program

Pathology experts profile the tumor with genetic testing, identifying mutations that guide medical oncology specialists to the most effective chemotherapy agents. Radiology specialists add perspective on diagnostic imaging results and radiation oncologists help the team determine treatments required. Oncology nurses provide patient care and education. Patients are connected with support groups, nutritional counseling, social services and pastoral support, and offered integrative therapies like Reiki. The result: the most effective cancer treatment, and the best patient well being.

The Latest Treatments, The Most Advanced Technology

We’re pioneering advanced medical technology like bracheatherapy to place radiation seeds directly into tumors, and ultrasound-guided EBUS technology to sample lymph nodes without traditional medial stinoscopy surgery. Now we can treat some tumors in just five days using specialized high-dose stereotactic radiation, and we’ve just introduced a new internal superdimension navigation system to locate and biopsy lung tumors that are otherwise unreachable. As innovators in techniques like robotic and video assisted thoracic surgery (VATS), our patients are recovering faster with smaller incisions. Needle biopsies were developed and perfected at Hartford Hospital, where we’re stepping up lung cancer prevention with new low-dose CT scan screening.

Research Outcomes